X-ZONE
LIVE

Serial Number

79297142

Owner

EQUALITY PRODUCTS LIMITED

Attorney

Jeff Goehring

Filing Date

Jun 9, 2020

Add to watchlist:

No watchlists yet
View on USPTO

X-ZONE Trademark

Serial Number: 79297142 • Registration: 6914777

X-ZONE is a trademark filed by EQUALITY PRODUCTS LIMITED on June 9, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

EQUALITY PRODUCTS LIMITED (2 trademarks)

56 Bush Road,

Entity Type: 99

Trademark Details

Filing Date

June 9, 2020

Registration Date

December 6, 2022

Published for Opposition

September 20, 2022

Goods & Services

Muscle pain relief and medicated performance gels, creams, topical sprays and roll ons; medicinal preparations for human use all in the form of balm; plant extracts for pharmaceutical purposes; medicinal herbs; medicinal oils; cannabis related products, namely, oils, salves, concentrated pastes, tinctures, tablets and capsules, each containing cannabis or derivatives of cannabis, namely, resins and oils for medical or therapeutic purposes, each for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, joint and muscle pain, muscle cramps, muscle spasms, to enhance mood and to improve general state of well-being; nutraceuticals and herbs for medicinal purposes each containing cannabis and derivatives of cannabis, namely, resins and oils, for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, joint and muscle pain, muscle cramps, muscle spasms, to enhance mood and to improve general state of well-being; analgesics; topical analgesic creams; antipyretic analgesics; anti-inflammatory analgesic plasters; pain relieving creams; pain relief preparations; multi-purpose medicated analgesic balms; effervescent analgesic pharmaceutical preparations; antiseptics; bath salts for medical purposes; bath preparations for medical purposes; herbal teas for medicinal purposes; medicated capillary lotions; medicated soap; medicated shampoos; medicinal tea; mineral waters for medical purposes; tissues impregnated with pharmaceutical skin lotions; mouthwashes for medical purposes; tinctures for medical purposes; oils, salves, concentrated pastes, tinctures, tablets and capsules each containing resins and oils derived from cannabis for medical purposes for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, joint and muscle pain, muscle cramps, muscle spasms, to enhance mood and to improve general state of well-being; nutraceuticals for medicinal purposes containing derivatives of cannabis, namely, resins and oils; topical skin creams and gels, bar and liquid soaps, bath additives, bath herbs, bath oils, body creams, body oils, face and body lotions, face and body milk, face lotion, and skin care preparations for medical purposes; oral sprays containing cannabis for medical purposes for use as central nervous system stimulants; topical creams, lotions, balms, oils, sprays, and transdermal patches for the relief of pain; medicinal, herbal and botanical preparations and supplements all for medical purposes in the form of oil extracts, oils, extracts, tinctures, resins, waxes, hashes, pastes, balms, salves, concentrates, lotions, sprays, ointments, pastes, tonics, liquids, powders, teas, coffees, beverages, topical skin creams, lotions and gels, pills, tablets, capsules, suppositories, skin patches, sublingual doses, and mucous membrane doses, sprays and liquids, transdermal patches and oral sprays, for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, joint and muscle pain, muscle cramps, muscle spasms, to enhance mood and to improve general state of well-being; insect repellents, insecticides and insect repellents; anti-fungal creams for medical use; fungicides; after-sun creams for medical use; medicated sun tanning preparations; aloe vera gel for therapeutic purposes; anti-bacterial throat sprays and mouth washes; medicated hair care preparations and lotions; decongestants; decongestant nasal sprays; medicated body and beauty care preparations, namely, preparations in the form of creams, gels and lotions, all for the care of dry skin; dermatologicals for treatment of eczema, psoriasis and dermatological conditions; medicated bath and shower additives; medicated preparations for the care and cleaning of hair; medicated preparations for aged skin, namely, anti-aging creams and anti-aging serums; acne and skin blemish treatment medications; anti-itch creams and ointments; pharmaceutical preparations for the relief of insect bites; preparations for the treatment of burns; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; all of the aforementioned goods containing cannabis ingredients being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and no cannabidiol (CBD)

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 19, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 23, 2023 FICS
FINAL DISPOSITION PROCESSED
Mar 23, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 6, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 6, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 6, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Oct 2, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 20, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 20, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 7, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 7, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 31, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 18, 2022 PREV
ASSIGNED TO LIE
Aug 15, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 11, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 11, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 11, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 11, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 11, 2022 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 11, 2022 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 19, 2022 PBCR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 17, 2022 OPNX
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2022 CNSA
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 30, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 30, 2022 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 23, 2022 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Feb 2, 2022 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Feb 2, 2022 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Feb 2, 2022 CNCF
NOTICE OF REVIVAL - E-MAILED
Jan 12, 2022 NREV
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 12, 2022 CRFA
ASSIGNED TO LIE
Jan 12, 2022 ALIE
PETITION GRANTED - RESPONSE RECEIVED
Jan 12, 2022 PGRR
ASSIGNED TO PETITION STAFF
Jan 11, 2022 APET
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 16, 2021 TROA
TEAS PETITION TO REVIVE RECEIVED
Nov 16, 2021 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 18, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 18, 2021 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 6, 2021 GNFN
FINAL REFUSAL E-MAILED
Apr 6, 2021 GNFR
FINAL REFUSAL WRITTEN
Apr 6, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 16, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 16, 2021 TROA
REFUSAL PROCESSED BY IB
Mar 15, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 25, 2021 RFCS
REFUSAL PROCESSED BY MPU
Feb 25, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 17, 2021 RFCR
NON-FINAL ACTION WRITTEN
Feb 16, 2021 CNRT
ASSIGNED TO EXAMINER
Feb 8, 2021 DOCK
ASSIGNED TO EXAMINER
Nov 9, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 6, 2020 MAFR
ASSIGNED TO EXAMINER
Nov 2, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 2, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 29, 2020 REPR